In one paragraphArticle in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Ibrahim MorganDepartment of Bioorganic Chemistry, Leibniz Institute of Plant Biochemistry, Weinberg 3, 06120, Halle (Saale), Germany.ORCID 0000-0002-4032-2691 Robert RennertDepartment of Bioorganic Chemistry, Leibniz Institute of Plant Biochemistry, Weinberg 3, 06120, Halle (Saale), Germany. robert.rennert@ipb-halle.de.ORCID 0000-0003-3665-6696 Robert BergerDepartment of Bioorganic Chemistry, Leibniz Institute of Plant Biochemistry, Weinberg 3, 06120, Halle (Saale), Germany.ORCID 0009-0000-9939-297X Sanja JelačaDepartment of Immunology, Institute for Biological Research "Siniša Stanković" - National Institute of the Republic of Serbia (IBISS), University of Belgrade, Bulevar Despota Stefana 142, 11108, Belgrade, Serbia.ORCID 0000-0002-9848-6859 Danijela Maksimović-IvanićDepartment of Immunology, Institute for Biological Research "Siniša Stanković" - National Institute of the Republic of Serbia (IBISS), University of Belgrade, Bulevar Despota Stefana 142, 11108, Belgrade, Serbia.ORCID 0000-0002-8006-5079 Duško DunđerovićInstitute of Pathology, Faculty of Medicine, University of Belgrade, Dr Subotića 1, 11000, Belgrade, Serbia.ORCID 0000-0001-9708-2089 Sanja MijatovićDepartment of Immunology, Institute for Biological Research "Siniša Stanković" - National Institute of the Republic of Serbia (IBISS), University of Belgrade, Bulevar Despota Stefana 142, 11108, Belgrade, Serbia.ORCID 0000-0001-9509-9098 Goran N KaluđerovićDepartment of Bioorganic Chemistry, Leibniz Institute of Plant Biochemistry, Weinberg 3, 06120, Halle (Saale), Germany.ORCID 0000-0001-5168-1000 Ludger A WessjohannDepartment of Bioorganic Chemistry, Leibniz Institute of Plant Biochemistry, Weinberg 3, 06120, Halle (Saale), Germany. wessjohann@ipb-halle.de.ORCID 0000-0003-2060-8235 Funding
AIP e.V. funded by IB (state of Saxony-Anhalt) through EFRE (Europäischer Fonds für Regionale Entwicklung) US2185Ministry of Science, Technological Development and Innovation of the Republic of Serbia 451-03-47/2023-01/ 200007
6 · The paper itselfAbstract
Quinazolinones, particularly 9-azaglycophymines, and closely related derivatives and precursors were tested in vitro against various breast cancer cell lines representing the major types of breast tumors. Among the 49 compounds tested, azaglycophymine derivative 19 with an electron-withdrawing substituent demonstrated the most significant anti-proliferative effects, with IC
Indexed as
ApoptosisBreast NeoplasmsCell ProliferationMice, Inbred BALB CAnimalsAntineoplastic AgentsCell Line, TumorFemaleGuanidinesHumansMCF-7 CellsMiceQuinazolinonesAntineoplastic AgentsGuanidinesQuinazolinonesAnticancerApoptosisBreast cancerQuinazolineQuinazolinoneStructure-activity-relationship
Identifiers
PMID39548116
PMCPMC11568214
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390